ArticleEnvironment & health (Washington, D.C.)2026
Global Burden of Non-Communicable Diseases from E‑Cigarette Exposure: Trend Analysis and 2050 Projections.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global rise in e-cigarette use has sparked significant public health concerns, particularly regarding its potential association with major non-communicable diseases (NCDs), including chronic respiratory conditions, cardiovascular diseases, and mental health disorders. A systematic evaluation of the NCD burden attributable to e-cigarettes is critically needed to inform policy. Therefore, this study aims to quantify the burden of major NCDs attributable to e-cigarette use between 2010 and 2021 and project future trends through 2050. This study used deidentified 2010-2021 NCD data from GBD 2021. We applied a comparative risk assessment framework to estimate the burden of NCDs attributable to e-cigarette use and used a generalized additive model to project future trends. We found that between 2010 and 2021, global prevalence of current e-cigarette use increased from 0.90% (95% CI, 0.46-1.48) to 8.73% (95% CI, 5.24-12.99). During this period, prevalent cases and DALYs for major NCDs showed consistent upward trends worldwide. Notably, NCD DALYs attributable to e-cigarette use increased from 2010 to 2021. Projections indicate that this concerning trend will continue, with marked increases in e-cigarette-attributable NCD burden anticipated through 2050. This study demonstrates the urgent need to incorporate electronic cigarette control measures into NCD prevention strategies, particularly targeting adolescent populations where usage rates are rising most rapidly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.